Click on the slide!

Urinary Tract Infection Test

Blue Cross One Step Urine UTI Test

Blue Cross One Step Urine Home Screening UTI Test is a fast and easy to use home screening test kit…

More...
Click on the slide!

Blue Care GCM1000

Blood Glucose Monitoring System

Glucoscreen GCM1000 Blood Glucose Monitoring System is a revolutionary blood sugar testing system that is portable and convenient with a…

More...
Click on the slide!

Blue Cross Pregnancy Test

Blue Cross Pregnancy Test Deluxe Plate

Blue Cross One Step Urine Home Screening Pregnancy Test detects the presence of hCG or human Chorionic Gonadotropin as low…

More...
Click on the slide!

Blue Cross Ovulation Test

Blue Cross One Step Urine Home Screening Ovulation Test

The Blue Cross One Step Urine Home Screening Ovulation Test is a rapid chromatographic immunoassay for the qualitative detection of…

More...
Frontpage Slideshow (version 2.0.0) - Copyright © 2006-2008 by JoomlaWorks
Home About Us

Company Background

 

Philippine Blue Cross Biotech Corporation is one of the assertive players in the pharmaceutical industry. A prominent entrepreneur established it in February 1997. The person behind all the emergent success of the business is Mr. Stephen C. Techico, the Chariman and CEO of Euro Group of Companies.

The company started out marketing Diagnostics Products. After effectively dominating its market, the company expanded into other health care products. The wide varieties of products being distributed are made available to different markets such as clinics, hospitals, laboratories, drugstores, government and other related institutions.

Through the years, the management, together with its empowered workforce, has continuously improved and provided quality products and services. The company has developed different techniques that would help in responding to the various needs of the customers. More so, the management always takes into account the vital role of its workforce in the attainment of the business goals to further boost the company's market standing and credibility.